Creatinine urinary

The aim is to remove the fluid gradually with a maximum weight loss of 0.5 kg/day in the absence of peripheral oedema, or 1.0 kg/day if peripheral oedema is present. Too rapid a diuresis will result in intravascular fluid loss rather than the peripheral oedema. The diuretic should be stopped if the serum sodium falls below 120 mmol/L or if there is a rising serum creatinine. Urinary electrolytes should be monitored to ensure that the spironolactone therapy is effective. The aim is to reverse the sodium/potassium ratio in the urine so that more sodium than potassium is excreted. Most frequent side-effects of spironolactone are those related to its anti-androgenic activity, such as decreased libido, impotence and gynaecomastia in men and menstrual irregularities in women. Other side-effects include hyperkalaemia, uraemia, hyponatraemia and nausea. 

Patients with psoriasis (57) and healthy volunteers (53) with no reported exposures to coal tar shampoos or ointments, self-applied either an ointment or a gel-based coal tar product, or both, to the entire body surface at least once a day, followed by UV-B treatment (Santella et al. 1994). The estimated exposure was 20-100 g/tar/day. Twenty-four-hour urine samples were collected from all subjects. Urinary 1-hydroxypyrene was analyzed by HPLC. Urinary PAH metabolites measured by the PAH-ELISA were elevated in patients (mean 730 1,370 mmol) as compared to untreated volunteers (110 90 mmol equivalents of B[a]P/mol creatinine). Urinary levels of 1-hydroxypyrene were also elevated in patients (mean 547 928 mmol/mol creatinine) compared with untreated volunteers (mean 0.14 0.17 mmol). 

In some patients with IgA nephropathy (IgAN), intraglomerular coagulation plays a role in depositing fibrinogen (235,236). IgAN patients treated with urokinase show a marked improvement in urinary protein concentration, semm creatinine, and blood urea nitrogen levels (237). 

RISK FOR INEFFECTIVE TISSUE PERFUSION RENAL When the patient is taking a drag tiiat is potentially toxic to die kidneys, die nurse must carefully monitor fluid intake and output. In some instances, die nurse may need to perform hourly measurements of die urinary output. Periodic laboratory tests are usually ordered to monitor the patient s response to therapy and to detect toxic drag reactions. Seram creatinine levels and BUN levels are checked frequentiy during the course of therapy to monitor kidney function. If the BUN exceeds 40 mg dL or if the serum creatinine level exceeds 3 mg cIL, the primary health care provider may discontinue the drug therapy or reduce the dosage until renal function improves. 

Creatinine is formed in muscle from creatine phosphate by irreversible, nonenzymatic dehydration and loss of phosphate (Figure 31-6). The 24-hour urinary excretion of creatinine is proportionate to muscle mass. Glycine, arginine, and methionine all participate in creatine biosynthesis. Synthesis of creatine is completed by methylation of guanidoacetate by S-adenosylmethio-nine (Figure 31-6). 

The study of the mechanism of urinary excretion of amylase and the amylase clearance has been the subject of many studies in recent years. Levitt et. al (79) studied the renal clearance of amylase in renal insufficiency, acute pancreatitis and macro-amylasemia. In acute pancreatitis, the kidney cleared amylase at a markedly increased rate. The ratio of the amylase clearance rate to the creatinine clearance rate (Cgm/Ccr) averaged 3 times normal early in the course of acute pancreatitis, and this elevation could persist after the serum amylase returned to normal. Comparison of an lase clearance to creatinine clearance was to minimize irrelevant changes due to variation in renal function. The increased clearance of amylase makes the urinary amylase a more sensitive indicator of pancreatitis. 

If the test is positive, the urine is examined microscopically for red blood cells. If no red blood cells are found, a tentative diagnosis of myoglobinuria is made, serum chemistries are obtained, and the patient is held to rule out rhabdomyolysis. If the uric acid and creatinine kinase (CK) values are normal, and the patient is asymptomatic, he/she is discharged from the hospital. Routine toxicology tests include urinary PCP, serum alcohol, and hypnotic screen. 

Color, yellow character, hazy glucose (-) ketones (-) specific gravity 1.020 pH 5.0 (+) protein coarse granular casts, 5 to 10/low-powered field white blood cell (WBC) count, 5 to 10/high-powered field red blood cell (RBC) count, 2 to 5/high-powered field no bacteria nitrite (-) blood small osmolality 325 mOsm urinary sodium 77 mEq/L (77 mmol/L) creatinine 63 mg/dL (5569 pmol/L)... 

Assess kidney function by evaluating a patient s signs and symptoms, laboratory test results, and urinary indices. Calculate a patient s creatinine clearance to evaluate the severity of kidney disease. 

At minimum, yearly laboratory evaluation of serum lipids, urinary microalbumin, and serum creatinine should be performed. If the patient is on a thiazolidinedione, liver function tests should be performed at least once a year. 

Monitor the patient for resolution of hematuria after each successive therapeutic intervention. Frequency of monitoring is based on the severity of hemorrhaging. Monitor urinary output and serum chemistries (including sodium, potassium, chloride, blood urea nitrogen, and serum creatinine) daily for renal dysfunction. Check the CBC at least daily to monitor hemoglobin and platelet count. 

Persistent diuresis, proteinuria, and an increased urinary protein/creatinine ratio were observed in rats receiving 1,000 mg/kg/day MIL-H-5606 for 26 days (Mattie et al. 1993). Hyaline droplets in the proximal tubules were also noted at histopathological examination. 

Polyalphaolefin Hydraulic Fluids. The only information on renal effects in humans or animals following inhalation, oral, or dermal exposure to polyalphaolefin hydraulic fluids is a report of increased urinary protein to creatinine ratio of rats orally exposed to MIL-H-83282 at 1,000 mg/kg/day for 4 weeks. Diuresis was noted in rats similarly exposed to MIL-H-83282LT (Mattie et al. 1993). 

To monitor the absorbed chlorpyrifos doses in human volunteers, urine was collected before and following a 4-hr activity period on the treated grass surface(re-entry). The urine was analyzed for 3,5,6-trichloropyridinol (3,5,6-TCP), the urinary metabolite of chlorpyrifos, and creatinine, which was determined to verify completeness of urine collection by each volunteer. 

Analysis of the urinary data. The amount of creatinine and 3,5,6-TCP in each urine collection was calculated from the volume of the urine specimen and the concentration of each in that urine specimen. The amount of creatinine excreted per day was compared across days for each volunteer and to standard literature values for creatinine excretion (i.e., mean 1.8 g/24 hr 95% range, 1.1 to 2.5 g/24 hr). The urine collection was considered to be complete if the amount of creatinine was consistent with the amount of creatinine in the other urine specimens provided by that individual and within the literature range for normal creatinine excretion. 

Blood lead levels, urinary lead levels, serum creatinine, blood urea nitrogen (BUN), creatinine clearance (CCT), and NAG were measured in 158 male and 51 female workers in a lead battery factory or a lead smelting plant in Japan (Ong et al. 1987). Controls consisted of 30 professional and laboratory staff members with no history of renal disease or lead exposure. The length of exposure to lead averaged 10.8 8.0 years with a range of 1-36 years. Exposure levels were not available, but indicators of lead body burden in the exposed workers were PbB level = 3.0-80.0 pg/dL and urinary lead level =... 

A weak but statistically significant positive association was found between PbB level and BUN, PbB level and serum creatinine CCT was reduced with increased PbB level. The same associations were found with urinary lead level. The NAG levels in the lead-exposed workers were significantly increased over control values, and significantly increased with increasing PbB level and urinary lead level (when the data were adjusted for age). These results indicate that lead exposure resulting in relatively low PbB levels can affect renal function. 

A report entitled Chemical Trespass was issued in May 2004 by the Pesticide Action Network (Schafer et al., 2006). It contained detailed analysis of 2000/01 National Health and Nutrition Examination Survey (NHANES) OP urinary metabolite data and used published methods to estimate exposure levels to parent compounds from creatinine corrected urinary metabolite levels. They focused on chlorpyrifos and its metabolite 3,4,6-trichloro-2-pyridinol (TCP), and found that chlorpyrifos exposures for children ages 6-11 and 12-19 exceeded EPA s chronic population-adjusted dose (cPAD) by surprisingly wide margins. Geometric mean TCP levels were 3 to 4.6 times higher than the EPA-estimated safe dose, as shown in Fig. 14.2. The more heavily exposed children received daily doses more than ten times the safe level. 

Renal function can be grossly assessed by hourly measurements of urine output, but estimation of creatinine clearance based on isolated serum creatinine values in critically ill patients may yield erroneous results. Decreased renal perfusion and aldosterone release result in sodium retention and, thus, low urinary sodium (<30 mEq/L). 

Peak urinary flow rate <10 mL/s Postvoid residual urine volume >25-50 mL Increased BUN and serum creatinine All of the above signs plus obstructive voiding symptoms and irritative voiding symptoms (signs of detrusor instability)... 

---